This clinical trial is focused on evaluating the effectiveness of two different sedation methods used during a screening procedure called a colonoscopy, which is often performed to check for colon cancer. The study compares the use of Remimazolam combined with Fentanyl against Midazolam combined with Fentanyl. Remimazolam and Midazolam are medications that help relax patients and make them sleepy during medical procedures, while Fentanyl is a pain reliever. The goal is to see if using Remimazolam with Fentanyl can make the procedure and recovery time shorter compared to using Midazolam with Fentanyl.

Participants in the study will receive one of the two sedation combinations before their colonoscopy. The study will measure how long it takes from the start of the medication until the patient meets the criteria to be safely discharged. Other aspects being observed include whether patients need extra time in a recovery room, their comfort and pain levels, how quickly the procedure reaches a certain point in the colon, and whether additional doses of Fentanyl or other sedatives are needed. The satisfaction of both the patients and the doctors performing the procedure will also be assessed, along with the patients’ cognitive function, which refers to their ability to think and remember, at the time of discharge.

The purpose of this study is to determine if Remimazolam with Fentanyl can improve the sedation process by making it quicker and more comfortable for patients undergoing a colonoscopy. This could potentially lead to better experiences for patients and more efficient procedures for healthcare providers.